The interaction of ervatamine and epiervatamine with the action potential Na+ ionophore.
D000200:Action Potentials / Q000187:drug effects*; D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001665:Binding Sites; D002460:Cell Line; D066298:In Vitro Techniques; D007473:Ion Channels / Q000187:drug effects*; D009374:Neoplasms, Experimental / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D051381:Rats; D046948:Secologanin Tryptamine Alkaloids; D012964:Sodium / Q000378:metabolism*; D013574:Synaptosomes / Q000187:drug effects; D013779:Tetrodotoxin / Q000494:pharmacology; D015016:Yohimbine / Q000494:pharmacology
D000470:Alkaloids; D007473:Ion Channels; D046948:Secologanin Tryptamine Alkaloids; D015016:Yohimbine; C017291:ervatamine; D013779:Tetrodotoxin; D012964:Sodium; D011188:Potassium